From the Departments of Otolaryngology-Head and Neck Surgery (M.R.C., A.I.A., D.P.S., Y.G., K.E.L., B.J.M., P.J.B., S.P.B., B.K.W., D.Q.S., C.T.G., M.C.S., J.P.C., C.C.D.S.) and Biomedical Engineering (M.R.C., A.I.A., B.J.M., P.J.B., C.C.D.S.), Johns Hopkins University School of Medicine, and Labyrinth Devices (M.A.R., N.S.V., C.C.D.S.) - both in Baltimore.
N Engl J Med. 2021 Feb 11;384(6):521-532. doi: 10.1056/NEJMoa2020457.
Bilateral vestibular hypofunction is associated with chronic disequilibrium, postural instability, and unsteady gait owing to failure of vestibular reflexes that stabilize the eyes, head, and body. A vestibular implant may be effective in alleviating symptoms.
Persons who had had ototoxic (7 participants) or idiopathic (1 participant) bilateral vestibular hypofunction for 2 to 23 years underwent unilateral implantation of a prosthesis that electrically stimulates the three semicircular canal branches of the vestibular nerve. Clinical outcomes included the score on the Bruininks-Oseretsky Test of Motor Proficiency balance subtest (range, 0 to 36, with higher scores indicating better balance), time to failure on the modified Romberg test (range, 0 to 30 seconds), score on the Dynamic Gait Index (range, 0 to 24, with higher scores indicating better gait performance), time needed to complete the Timed Up and Go test, gait speed, pure-tone auditory detection thresholds, speech discrimination scores, and quality of life. We compared participants' results at baseline (before implantation) with those at 6 months (8 participants) and at 1 year (6 participants) with the device set in its usual treatment mode (varying stimulus pulse rate and amplitude to represent rotational head motion) and in a placebo mode (holding pulse rate and amplitude constant).
The median scores at baseline and at 6 months on the Bruininks-Oseretsky test were 17.5 and 21.0, respectively (median within-participant difference, 5.5 points; 95% confidence interval [CI], 0 to 10.0); the median times on the modified Romberg test were 3.6 seconds and 8.3 seconds (difference, 5.1; 95% CI, 1.5 to 27.6); the median scores on the Dynamic Gait Index were 12.5 and 22.5 (difference, 10.5 points; 95% CI, 1.5 to 12.0); the median times on the Timed Up and Go test were 11.0 seconds and 8.7 seconds (difference, 2.3; 95% CI, -1.7 to 5.0); and the median speeds on the gait-speed test were 1.03 m per second and 1.10 m per second (difference, 0.13; 95% CI, -0.25 to 0.30). Placebo-mode testing confirmed that improvements were due to treatment-mode stimulation. Among the 6 participants who were also assessed at 1 year, the median within-participant changes from baseline to 1 year were generally consistent with results at 6 months. Implantation caused ipsilateral hearing loss, with the air-conducted pure-tone average detection threshold at 6 months increasing by 3 to 16 dB in 5 participants and by 74 to 104 dB in 3 participants. Changes in participant-reported disability and quality of life paralleled changes in posture and gait.
Six months and 1 year after unilateral implantation of a vestibular prosthesis for bilateral vestibular hypofunction, measures of posture, gait, and quality of life were generally in the direction of improvement from baseline, but hearing was reduced in the ear with the implant in all but 1 participant. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT02725463.).
双侧前庭功能低下可导致慢性平衡失调、姿势不稳和步态不稳,这是由于前庭反射失败所致,这些反射可稳定眼睛、头部和身体。前庭植入物可能有助于缓解症状。
患有耳毒性(7 名参与者)或特发性(1 名参与者)双侧前庭功能低下 2 至 23 年的患者接受了单侧植入物治疗,该植入物可电刺激前庭神经的三个半规管分支。临床结果包括 Bruininks-Oseretsky 运动能力测试的平衡子测试分数(范围 0 至 36,分数越高表示平衡能力越好)、改良 Romberg 测试失败时间(范围 0 至 30 秒)、动态步态指数分数(范围 0 至 24,分数越高表示步态表现越好)、完成计时起立行走测试的时间、步态速度、纯音听觉检测阈值、言语辨别分数和生活质量。我们将参与者在基线(植入前)的结果与 6 个月(8 名参与者)和 1 年(6 名参与者)的结果进行了比较,设备分别处于其常规治疗模式(变化刺激脉冲率和幅度以代表旋转头部运动)和安慰剂模式(保持脉冲率和幅度恒定)。
Bruininks-Oseretsky 测试的中位数基线和 6 个月得分分别为 17.5 和 21.0(中位数参与者内差异为 5.5 分;95%置信区间 [CI],0 至 10.0);改良 Romberg 测试的中位数时间分别为 3.6 秒和 8.3 秒(差异为 5.1;95%CI,1.5 至 27.6);动态步态指数的中位数分数分别为 12.5 和 22.5(差异为 10.5 分;95%CI,1.5 至 12.0);计时起立行走测试的中位数时间分别为 11.0 秒和 8.7 秒(差异为 2.3;95%CI,-1.7 至 5.0);步态速度测试的中位数速度分别为 1.03 米/秒和 1.10 米/秒(差异为 0.13;95%CI,-0.25 至 0.30)。安慰剂模式测试证实,改善归因于治疗模式刺激。在 6 名还在 1 年内进行评估的参与者中,从基线到 1 年的参与者内变化与 6 个月的结果基本一致。植入物导致同侧听力损失,5 名参与者的气导纯音平均检测阈值在 6 个月时增加了 3 至 16 dB,3 名参与者增加了 74 至 104 dB。参与者报告的残疾和生活质量的变化与姿势和步态的变化平行。
在因双侧前庭功能低下而单侧植入前庭假体后的 6 个月和 1 年,姿势、步态和生活质量的测量结果通常朝着从基线改善的方向发展,但除 1 名参与者外,所有参与者的植入耳听力均下降。(由美国国立卫生研究院和其他机构资助;ClinicalTrials.gov 编号,NCT02725463)。